Intelligent Ultrasound Group PLC Notice of AGM and 2021 Report and Accounts (1227N)
30 May 2022 - 4:01PM
UK Regulatory
TIDMIUG
RNS Number : 1227N
Intelligent Ultrasound Group PLC
30 May 2022
Intelligent Ultrasound Group plc
("Intelligent Ultrasound" or the "Group" or the "Company")
Notice of Annual General Meeting and 2021 Report and
Accounts
Intelligent Ultrasound Group plc (AIM: IUG), the 'classroom to
clinic' ultrasound company, specialising in artificial intelligence
(AI) software and simulation, announces that the following
documents have been published on the Company's website
www.intelligentultrasound.com/reports-presentations/ .
-- 2021 Report and Accounts;
-- Notice of 2022 Annual General Meeting (AGM Notice); and
-- Form of Proxy
The Company has historically adopted a higher standard of
governance which recommends all Directors offer themselves for
re-election annually. To ensure that this higher standard of
governance is not in conflict with the Articles of Association, the
Company is proposing a resolution at this year's AGM to amend the
Articles to require all Directors to retire prior to offering
themselves for re-election annually.
At this year's AGM, all Directors will therefore retire. The
biographical details of the Directors who are offering themselves
for re-election at the meeting are set out in the annual report and
accounts and appear on the Company's website.
Professor Nazar Amso and David Baynes, who have been Directors
within the Group respectively for 17 and 12 years, will be retiring
from the Board and not standing for re-election. The Board would
like to take this opportunity to thank each of Professor Nazar
Amso, the founder of the original Company, and David Baynes, the
representative of the original major investor, for their
significant contribution to the Company over the past years.
Printed copies of the 2021 Report and Accounts and the 2022 AGM
Notice have been posted to those shareholders that have requested
hard copies.
The 2022 AGM will be held at the Memery Crystal's offices at 165
Fleet Street, London EC4A 2DY at 11:00am on 22 June 2022.
For further information, please contact:
Intelligent Ultrasound Group www. intelligentultrasound.com
plc
Stuart Gall, CEO Tel: +44 (0)29 2075 6534
Helen Jones, CFO
Cenkos Securities - Nominated Advisor
and Broker
Giles Balleny/Max Gould (Corporate Tel: +44 (0)20 7397 8900
Finance)
Michael Johnson/Julian Morse
(Sales)
Walbrook PR Tel: +44 (0)20 7933 8780 or intelligentultrasound@walbrookpr.com
Anna Dunphy/Paul McManus Mob: +44 (0)7876 741 001 / Mob: +44
(0)7980 541 893
About Intelligent Ultrasound Group
Intelligent Ultrasound (AIM: IUG) is one of the world's leading
'classroom to clinic' ultrasound companies, specialising in
real-time hi-fidelity virtual reality simulation for the ultrasound
training market ('classroom') and artificial intelligence-based
clinical image analysis software tools for the diagnostic medical
ultrasound market ('clinic'). Based in Cardiff in the UK and
Atlanta in the US, the Group has two revenue streams:
Simulation
Real-time hi-fidelity ultrasound education and training through
simulation. Our main products are the ScanTrainer obstetrics and
gynaecology training simulator, the HeartWorks echocardiography
training simulator, the BodyWorks Eve Point of Care and Emergency
Medicine training simulator with Covid-19 module and the new
BabyWorks Neonate and Paediatric training simulator. To date over
1,350 simulators have been sold to over 650 medical institutions
around the world.
Clinical AI software
Deep learning-based algorithms to make ultrasound machines
smarter and more accessible using our proprietary ScanNav
ultrasound image analysis technology. Current products on the
market utilising this technology are GE Healthcare's SonoLyst
software that is incorporated in their Voluson SWIFT ultrasound
machine; ScanNav Anatomy PNB that simplifies ultrasound-guided
needling by providing the user with real-time AI-based anatomy
highlighting for a range of medical procedures; and NeedleTrainer
that teaches real-time ultrasound-guided needling and incorporates
ScanNav Anatomy PNB.
www.intelligentultrasound.com
NOTE: ScanNav Anatomy PNB is CE approved, but not yet available
for sale in the US or any other territory requiring government
approval for this type of product.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOABKOBBBBKDDPB
(END) Dow Jones Newswires
May 30, 2022 02:01 ET (06:01 GMT)
Intelligent Ultrasound (LSE:MED)
Historical Stock Chart
From Dec 2024 to Jan 2025
Intelligent Ultrasound (LSE:MED)
Historical Stock Chart
From Jan 2024 to Jan 2025